ABL1 and breast cancer: Geminin- or c-Abl-depleted cells developed <20% size tumors, compared to control cells16, supporting the intimate relationship between c-Abl and geminin and giving credence to using imatinib to treat GemOE mammary tumors (especially TNBC) see introduction and16.